Chris’s research focuses on the development of new antibody and nano-medicine based approaches for the treatment of cancer. His group also works extensively on understanding the complex milieu of the tumour microenvironment, and in particular protease species that are up-regulated in aggressive and metastatic tumours.
We are interested in hosting visiting researchers and PhD students with an interest in; nanomedicine, antibody therapeutics, proteases and pancreatic cancer
PUBLIC OUTREACH AND KEY ACHIEVEMENTS
Our dedicated hub for postgraduate students, providing state-of-the-art facilities for study, and high-quality training and development programmes within a diverse interdisciplinary community.The gateway to your postgraduate experience
Queen's University Belfast is committed to Equality, Diversity and Inclusion.
For more information please read our Equality and Diversity Policy.
Queen's University Belfast is registered with the Charity Commission for Northern Ireland NIC101788
VAT registration number: GB 254 7995 11